48 results
424B3
XCUR
Exicure Inc
8 Aug 18
Prospectus supplement
12:00am
Agency (“EMA”) or European Union national competent authorities, regarding the scope or design of our clinical trials;
delays in enrolling research … for the treatment of a specific indication in the European Union before the application for marketing authorization is made. Sponsors of orphan drugs
424B3
8xq5l7 z2rxo
8 Aug 18
Prospectus supplement
12:00am
424B3
avvrf9y3yxrym8k6lj
7 Nov 19
Prospectus supplement
4:30pm
424B3
09ge2qbklzvl
6 Nov 18
Prospectus supplement
4:56pm
424B3
zkzf22
6 Nov 18
Prospectus supplement
4:57pm
424B3
qzki3oyj
7 Nov 19
Prospectus supplement
4:34pm
424B3
f0zxtjlx2np0c3
10 May 19
Prospectus supplement
4:38pm
424B3
g81gvaycg
10 May 19
Prospectus supplement
4:35pm